Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy

We previously analysed clinical and immunological parameters under Trichuris suis ova (TSO) therapy in four patients with secondary progressive multiple sclerosis. The serum Brain-derived neurotrophic factor (BDNF) levels of these four patients were assessed before, during and after therapy with TSO...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosche, Berit, Werner, Jonas, Benzel, Friderike Joëlle, Harms, Lutz, Danker-Hopfe, Heidi, Hellweg, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: EDP Sciences 2013
Materias:
Short Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866952/
https://www.ncbi.nlm.nih.gov/pubmed/24351232
http://dx.doi.org/10.1051/parasite/2013056
_version_ 1782296248056807424
author Rosche, Berit
Werner, Jonas
Benzel, Friderike Joëlle
Harms, Lutz
Danker-Hopfe, Heidi
Hellweg, Rainer
author_facet Rosche, Berit
Werner, Jonas
Benzel, Friderike Joëlle
Harms, Lutz
Danker-Hopfe, Heidi
Hellweg, Rainer
author_sort Rosche, Berit
collection PubMed
description We previously analysed clinical and immunological parameters under Trichuris suis ova (TSO) therapy in four patients with secondary progressive multiple sclerosis. The serum Brain-derived neurotrophic factor (BDNF) levels of these four patients were assessed before, during and after therapy with TSO and showed significant decrease of BDNF during TSO therapy (p < 0.05).
format Online
Article
Text
id pubmed-3866952
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher EDP Sciences
record_format MEDLINE/PubMed
spelling pubmed-38669522013-12-30 Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy Rosche, Berit Werner, Jonas Benzel, Friderike Joëlle Harms, Lutz Danker-Hopfe, Heidi Hellweg, Rainer Parasite Short Note We previously analysed clinical and immunological parameters under Trichuris suis ova (TSO) therapy in four patients with secondary progressive multiple sclerosis. The serum Brain-derived neurotrophic factor (BDNF) levels of these four patients were assessed before, during and after therapy with TSO and showed significant decrease of BDNF during TSO therapy (p < 0.05). EDP Sciences 2013 2013-12-19 /pmc/articles/PMC3866952/ /pubmed/24351232 http://dx.doi.org/10.1051/parasite/2013056 Text en © B. Rosche et al., published by EDP Sciences, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Note
Rosche, Berit
Werner, Jonas
Benzel, Friderike Joëlle
Harms, Lutz
Danker-Hopfe, Heidi
Hellweg, Rainer
Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy
title Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy
title_full Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy
title_fullStr Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy
title_full_unstemmed Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy
title_short Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy
title_sort serum levels of brain-derived neurotrophic factor (bndf) in multiple sclerosis patients with trichuris suis ova therapy
topic Short Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866952/
https://www.ncbi.nlm.nih.gov/pubmed/24351232
http://dx.doi.org/10.1051/parasite/2013056
work_keys_str_mv AT roscheberit serumlevelsofbrainderivedneurotrophicfactorbndfinmultiplesclerosispatientswithtrichurissuisovatherapy
AT wernerjonas serumlevelsofbrainderivedneurotrophicfactorbndfinmultiplesclerosispatientswithtrichurissuisovatherapy
AT benzelfriderikejoelle serumlevelsofbrainderivedneurotrophicfactorbndfinmultiplesclerosispatientswithtrichurissuisovatherapy
AT harmslutz serumlevelsofbrainderivedneurotrophicfactorbndfinmultiplesclerosispatientswithtrichurissuisovatherapy
AT dankerhopfeheidi serumlevelsofbrainderivedneurotrophicfactorbndfinmultiplesclerosispatientswithtrichurissuisovatherapy
AT hellwegrainer serumlevelsofbrainderivedneurotrophicfactorbndfinmultiplesclerosispatientswithtrichurissuisovatherapy

Ejemplares similares